Navigation Links
Sinovac's Stock Exchange Listing Moves to NASDAQ Global Select Market
Date:12/31/2010

BEIJING, Dec. 31, 2010 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, announced today its common shares will be listed on the NASDAQ Global Select Market effective January 3, 2011.  The Company received notification from the NASDAQ Stock Market dated December 7, 2010 that as part of the exchange's annual review of Global Market issuers it has met the initial listing requirements of the Global Select Market and is eligible for inclusion. Sinovac's common shares commenced trading on the NASDAQ Global Market on November 16, 2009.

Dr. Weidong Yin, Chairman, President & CEO, stated, "We look forward to trading on the Global Select Market in January 2011 as we have met the high listing standards of this market tier.  We are focused on advancing our development pipeline and commercializing our high quality vaccines as we build shareholder value as a leading China-based biopharmaceutical company."

AboutSinovacSinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacture and commercialization of vaccines that protect against human infectious diseases including hepatitis A, seasonal influenza, H5N1 (bird flu) pandemic influenza and H1N1 influenza. In 2009, Sinovac was the first company worldwide to receive approval for its H1N1 influenza vaccine, PANFLU.1, and has received orders from the Chinese Central Government pursuant to the government stockpiling program. The Company is developing a number of new vaccine products, including vaccines for pneumococcal conjugate, enterovirus 71 (EV71) (against Hand, Foot & Mouth Disease), Japanese Encephalitis, animal and human rabies, HIB and epidemic meningitis, chickenpox, mumps and rubella. Its wholly owned subsidiary, Tangshan Yian, is focusing on the research, development, manufacturing and commercialization of animal vaccines and has completed the field trials for an independently developed inactivated animal rabies vaccine, which is anticipated to be launched into market in 2011.

SafeHarborStatementThis announcement contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by words or phrases such as "will," "expects," "anticipates," "future," "intends," "plans," "believes," "estimates" and similar statements. Among other things, the business outlook and quotations from management in this press release contain forward-looking statements. Statements that are not historical facts, including statements about Sinovac's beliefs and expectations, are forward-looking statements. Forward-looking statements involve inherent risks and uncertainties. A number of important factors could cause actual results to differ materially from those contained in any forward-looking statement. Sinovac does not undertake any obligation to update any forward-looking statement, except as required under applicable law.Helen Yang/Chris Lee
Sinovac Biotech Ltd.
Tel:  +86-10-8279-9871/9659
Fax:  +86-10-6296-6910
Email: ir@sinovac.comInvestors:
Stephanie Carrington/Amy Glynn
The Ruth Group
Tel:  +1-646-536-7017/7023
Email: scarrington@theruthgroup.com
aglynn@theruthgroup.comMedia
Jason Rando
The Ruth Group
Tel:  +1-646-536-7025
Email:  jrando@theruthgroup.com
'/>"/>

SOURCE Sinovac Biotech Ltd.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Heska Corporation Announces Stockholder Approval of Reverse Split
2. Webcast Alert: Heska Corporations Special Meeting of Stockholders Webcast
3. Cannabis Science Files Preliminary 14c Information Statement, the Action is to Create a New Class of Common Stock and Issue Dividend
4. Cardica Announces $10 Million At-The-Market Common Stock Financing Agreement
5. HeartWare International, Inc. Announces Completion of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
6. HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock
7. HeartWare International, Inc. Announces Concurrent Public Offerings of Convertible Senior Notes and Common Stock
8. Vermillion Reappoints Three Directors, Approves a New Stock Incentive Plan, and Ratifies PricewaterhouseCoopers LLP as Its Accounting Firm
9. AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
10. Mylan Announces the Conversion of its Preferred Stock into Common Stock
11. Watson Announces Pricing of Secondary Offering By Selling Stockholder
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... FARMINGDALE, N.Y., Feb. 9, 2016  Misonix, Inc. ... company that designs, manufactures and markets innovative therapeutic ... wound debridement, cosmetic surgery, laparoscopic surgery and other ... second quarter and the first half of fiscal ... --> --> Highlights ...
(Date:2/9/2016)... 2016  Unilife Corporation ("Unilife" or "Company") (NASDAQ: UNIS ... systems, today announced its financial results for the second quarter of ... Financial Results for the ... Revenue for the second quarter of fiscal ... period last year.  Cash receipts from customers for the second quarter ...
(Date:2/9/2016)... Pharmaceuticals plc (Nasdaq: JAZZ ) today announced that ... year financial results on Tuesday, February 23, 2016, after ... host a live audio webcast immediately following the announcement ... quarter and full year 2015 financial results and provide ... financial results. www.jazzpharmaceuticals.com .  Please connect to ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Workrite Ergonomics this week announced the launch ... mounts ever. , “Our goal was to develop a product from the ground ... we have ever created.” said Darren Hulsey, Product Manager for Workrite Ergonomics. “The ...
(Date:2/10/2016)... Henderson, Tennessee (PRWEB) , ... February 09, 2016 , ... ... the reins for Summer 2016. FHU President Joe Wiley made the announcement Monday night, ... , Brad Montague, a 2003 graduate of FHU and the creator of GO! Camp, ...
(Date:2/10/2016)... ... February 09, 2016 , ... ... the cause of injury may be one of many possible sources: sports, car ... Continuing Education Course , Mastering Rehab Solutions for the Complexities of Concussions ...
(Date:2/9/2016)... ... February 09, 2016 , ... Interstate Restoration LLC, ... disaster, announced today the acquisition of Hawaii DKI. Hawaii DKI is one of ... in like-minded companies who excel at service and response helps support our goal ...
(Date:2/9/2016)... ... 09, 2016 , ... Cirracore Enterprise Cloud, today announced that ... the cloud. Cirracore provides a secure VMware® vCloud Air based cloud that ... Transformation Solutions (TSL Partners) provides a full range of services from planning, discovery, ...
Breaking Medicine News(10 mins):